Big investments in Danish life science industry make 2021 historic year for raising capital
In 2021, Danish life science firms have brought in record sums and next year is looking even better, several venture funds assess. However, renewed Covid-19 fears, bubble tendencies and – paradoxically – current year's big investments may prove roadblocks for next year's promises.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
In the year coming to an end soon, millions upon millions of Danish kroner have poured into a number of Danish life science firms to such a degree that 2021 has become the best year for raising capital in the domestic industry ever.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
